AbbVie: Wait, I Thought It Was Good News?

AbbVie (ABBV) reported stronger-than-forecast earnings this morning, so it wasn’t a surprise when shares opened up 1.2%. What is a surprise? That AbbVie has given back those gains and then some. Evercore ISI’s Mark Schoenebaum hazards a guess as to why: brendan mcdermid/Reuters In a long answer to my operating margin/expense question, ABBV CEO basically reiterated that he’s strongly [...]